Rohto Pharmaceutical Co.,Ltd.

TSE:4527.T

3383 (JPY) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 270,840238,664199,646181,053188,375183,672171,795154,599166,477151,994144,082128,666120,423115,262113,430110,601108,206
Cost of Revenue 115,906101,24383,15774,32674,13574,04870,74663,25467,25061,39557,92452,79249,92847,32346,64945,39943,522
Gross Profit 154,934137,421116,489106,727114,240109,624101,04991,34599,22790,59986,15875,87470,49567,93966,78165,20264,684
Gross Profit Ratio 0.5720.5760.5830.5890.6060.5970.5880.5910.5960.5960.5980.590.5850.5890.5890.590.598
Reseach & Development Expenses 13,46111,0658,7407,9037,0506,8316,5536,1235,8115,5854,5474,0623,7173,6973,7333,7353,797
General & Administrative Expenses 47,08700000000000907926853850909
Selling & Marketing Expenses 54,21946,46738,11440,52547,92747,67944,84540,86947,98844,66240,24735,23132,90831,16830,33929,38629,251
SG&A 101,30646,46738,11440,52547,92747,67944,84540,86947,98844,66240,24735,23133,81532,09431,19230,23630,160
Other Expenses 505-63246260-33-40100203-1193013161384364249330-282
Operating Expenses 114,767103,45787,13583,73291,67988,80781,95975,88883,54077,43469,33061,48946,02944,14644,16343,36241,629
Operating Income 40,16733,95929,34922,99023,08520,81219,08715,45115,68313,15916,82114,38013,62413,10512,54411,63813,037
Operating Income Ratio 0.1480.1420.1470.1270.1230.1130.1110.10.0940.0870.1170.1120.1130.1140.1110.1050.12
Total Other Income Expenses Net 1,351751-2401,139-1,151-4,514-2,270-704-1,383586-2,228-754-10,378-10,363-10,206-12,596-10,687
Income Before Tax 41,51834,29027,95323,00621,73016,30016,82014,75214,30313,75114,59913,63014,08813,43012,4129,24412,368
Income Before Tax Ratio 0.1530.1440.140.1270.1150.0890.0980.0950.0860.090.1010.1060.1170.1170.1090.0840.114
Income Tax Expense 10,1237,8606,8036,2366,4486,4817,4834,7385,2175,1235,6515,5285,9445,4934,6393,0984,847
Net Income 30,93626,37721,12716,74315,4109,7999,28910,0119,0988,6318,9478,0878,1847,9667,7686,1397,525
Net Income Ratio 0.1140.1110.1060.0920.0820.0530.0540.0650.0550.0570.0620.0630.0680.0690.0680.0560.07
EPS 135.6115.6292.6173.3967.564340.7743.9840.0238.0338.5834.3934.833.8833.0326.2132.55
EPS Diluted 135.21115.2992.3473.1867.3642.8340.643.7939.8537.8738.4134.2434.6633.7332.8926.0431.98
EBITDA 48,85443,30138,16431,82429,26125,52024,90422,02021,95120,56323,31920,45729,84128,78028,61927,58227,353
EBITDA Ratio 0.180.1810.1910.1760.1550.1390.1450.1420.1320.1350.1620.1590.2480.250.2520.2490.253